We are live on
!
Find out more
FA
Fagan Associates Portfolio holdings
AUM
$719M
1-Year Est. Return
26.65%
This Fund
S&P 500
This Quarter
Est. Return
+1.4%
1 Year Est. Return
+26.65%
3 Year Est. Return
+87.69%
5 Year Est. Return
+107.31%
10 Year Est. Return
+467.14%
AUM
$156M
AUM Growth
+$4.81M
(+3.2%)
Cap. Flow
+$5.92M
Cap. Flow
% of AUM
3.8%
Top 10 Holdings %
Top 10 Hldgs %
34.74%
Holding
105
New
16
Increased
44
Reduced
31
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.39M |
| 2 |
AbbVie
ABBV
|
+$1.41M |
| 3 |
AT&T
T
|
+$1.25M |
| 4 |
Vanguard Total Bond Market
BND
|
+$1.25M |
| 5 |
HCA Healthcare
HCA
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delta Air Lines
DAL
|
+$1.52M |
| 2 |
D.R. Horton
DHI
|
+$1.43M |
| 3 |
Apple
AAPL
|
+$1.25M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$1M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$958K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.52% |
| 2 | Communication Services | 12.91% |
| 3 | Financials | 12.32% |
| 4 | Healthcare | 10.94% |
| 5 | Technology | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.89T
| $6.45M | 4.14% |
269,688
-50,360
| -16% | -$1.25M |
|
2
Nike
NKE
$61.9B
| $6.24M | 4.01% |
113,102
-5,098
| -4% | -$290K |
|
3
State Street SPDR S&P Dividend ETF
SDY
$21.9B
| $6.08M | 3.91% |
72,440
+1,590
| +2% | +$129K |
|
4
Meta Platforms (Facebook)
META
$1.51T
| $6.08M | 3.9% |
53,177
| – | – |
|
5
Visa
V
$677B
| $5.08M | 3.26% |
68,464
-129
| -0.2% | -$10.1K |
|
6
Mastercard
MA
$477B
| $5M | 3.21% |
56,815
-725
| -1% | -$69.2K |
|
7
Starbucks
SBUX
$118B
| $4.92M | 3.16% |
86,050
+444
| +0.5% | +$25.2K |
|
8
Lowe's Companies
LOW
$116B
| $4.87M | 3.13% |
61,504
-6,879
| -10% | -$532K |
|
|
9
Vanguard Total Bond Market
BND
$157B
| $4.76M | 3.06% |
56,412
+15,021
| +36% | +$1.25M |
|
10
Alphabet (Google) Class A
GOOGL
$3.91T
| $4.61M | 2.96% |
131,000
+3,600
| +3% | +$132K |
|
11
GE Aerospace
GE
$367B
| $4.49M | 2.89% |
29,771
+201
| +0.7% | +$29.3K |
|
12
JPMorgan Chase
JPM
$939B
| $4.34M | 2.79% |
69,780
+385
| +0.6% | +$24K |
|
13
Microsoft
MSFT
$2.84T
| $4.28M | 2.75% |
83,641
+4,412
| +6% | +$229K |
|
14
Vanguard Total International Bond ETF
BNDX
$82B
| $3.57M | 2.3% |
64,151
+12,317
| +24% | +$674K |
|
15
Verizon
VZ
$194B
| $3.44M | 2.21% |
61,559
+330
| +0.5% | +$17.1K |
|
|
16
Gilead Sciences
GILD
$161B
| $3.18M | 2.05% |
+38,165
| New | +$3.39M |
|
|
CELG
17
DELISTED
Celgene Corp
CELG
| $3.11M | 2% |
31,510
+105
| +0.3% | +$10.9K |
|
18
Bank of America
BAC
$435B
| $2.9M | 1.86% |
218,237
+421
| +0.2% | +$5.91K |
|
19
Pfizer
PFE
$140B
| $2.75M | 1.77% |
82,322
+4,165
| +5% | +$133K |
|
20
Cisco
CSCO
$450B
| $2.5M | 1.61% |
87,106
+5,849
| +7% | +$164K |
|
|
TWX
21
DELISTED
Time Warner Inc
TWX
| $2.47M | 1.59% |
33,575
+350
| +1% | +$25.9K |
|
22
Schwab US Broad Market ETF
SCHB
$42.8B
| $2.42M | 1.56% |
288,780
+22,572
| +8% | +$187K |
|
23
Johnson & Johnson
JNJ
$635B
| $2.35M | 1.51% |
19,388
-293
| -1% | -$33.3K |
|
24
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $2.34M | 1.5% |
58,686
+7,523
| +15% | +$295K |
|
25
ConocoPhillips
COP
$147B
| $2.3M | 1.48% |
52,768
-40
| -0.1% | -$1.76K |
|
Similar funds
EI
SAM
KC
TFA
WRPWM
WLIM
NI
CFO
Fagan Associates's Q2 2016 Portfolio in Review
As of Q2 2016, Fagan Associates held 105 positions worth $156M, up 3.2% from $151M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Fagan Associates deployed $5.92M of net new capital in Q2 2016, opening 16 new positions and adding to 44 existing holdings. Its largest new stake was Gilead Sciences: 38,165 shares worth $3.18M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 17% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was D.R. Horton, an estimated $1.43M trimmed.
- Fagan Associates's largest Q2 2016 buy was Gilead Sciences: 38,165 shares worth $3.18M.
- Fagan Associates added most to Vanguard Total Bond Market in Q2 2016, an estimated $1.25M increase.
- Fagan Associates's biggest Q2 2016 reduction was D.R. Horton, cutting an estimated $1.43M.
- Fagan Associates fully exited Delta Air Lines in Q2 2016, selling an estimated $1.52M.
- Fagan Associates's ten largest holdings make up 35% of its $156M portfolio in Q2 2016.
- Fagan Associates opened 16 new positions and closed 10 in Q2 2016.
- Fagan Associates's portfolio value rose 3.2% quarter-over-quarter to $156M.
Based on Fagan Associates's 13F filing for Q2 2016, filed 5 Aug 2016.